SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 240 filers reported holding SALIX PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2015 | $63,573,000 | +41.3% | 367,887 | -6.0% | 0.04% | +38.5% |
Q4 2014 | $44,994,000 | -72.5% | 391,459 | -62.6% | 0.03% | -73.5% |
Q3 2014 | $163,437,000 | -24.1% | 1,046,068 | -40.1% | 0.10% | -22.8% |
Q2 2014 | $215,271,000 | +22.6% | 1,745,238 | +3.0% | 0.13% | +21.0% |
Q1 2014 | $175,539,000 | -5.1% | 1,694,261 | -17.6% | 0.10% | -6.2% |
Q4 2013 | $185,010,000 | +32.6% | 2,057,050 | -1.4% | 0.11% | +21.7% |
Q3 2013 | $139,507,000 | +13.5% | 2,085,937 | +12.3% | 0.09% | +8.2% |
Q2 2013 | $122,900,000 | – | 1,857,879 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 467,943 | $30,954,000 | 11.01% |
TANG CAPITAL MANAGEMENT LLC | 300,000 | $19,845,000 | 7.82% |
OAK RIDGE INVESTMENTS LLC | 1,382,895 | $91,478,000 | 2.87% |
SECTOR GAMMA AS | 147,001 | $9,724,000 | 2.84% |
Credo Capital Management, LLC | 38,869 | $2,571,000 | 1.98% |
Cardinal Capital Management | 48,226 | $3,190,000 | 1.89% |
ZEVENBERGEN CAPITAL INVESTMENTS LLC | 626,800 | $41,463,000 | 1.68% |
HERNDON CAPITAL MANAGEMENT LLC | 1,284,472 | $84,967,823,000 | 1.27% |
CATAPULT CAPITAL MANAGEMENT LLC | 45,000 | $2,977,000 | 1.24% |
Pier Capital, LLC | 108,556 | $7,181,000 | 1.10% |